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Abstract
Background: Copper is an essential trace element that plays a critical role in the survival of all
living organisms. Menkes disease and occipital horn syndrome (OHS) are allelic disorders of copper
transport caused by defects in a X-linked gene (ATP7A) that encodes a P-type ATPase that
transports copper across cellular membranes, including the trans-Golgi network. Genetic studies in
yeast recently revealed a new family of cytoplasmic proteins called copper chaperones which bind
copper ions and deliver them to specific cellular pathways. Biochemical studies of the human
homolog of one copper chaperone, ATOX1, indicate direct interaction with the Menkes/OHS
protein. Although no disease-associated mutations have been reported in ATOX1, mice with
disruption of the ATOX1 locus demonstrate perinatal mortality similar to that observed in the
brindled mice (Mobr), a mouse model of Menkes disease. The cDNA sequence for ATOX1 is known,
and the genomic organization has not been reported.
Results: We determined the genomic structure of ATOX1. The gene contains 4 exons spanning
a genomic distance of approximately 16 kb. The translation start codon is located in the 3' end of
exon 1 and the termination codon in exon 3. We developed a PCR-based assay to amplify the
coding regions and splice junctions from genomic DNA. We screened for ATOX1 mutations in
two patients with classical Menkes disease phenotypes and one individual with occipital horn
syndrome who had no alterations detected in ATP7A, as well as an adult female with chronic
anemia, low serum copper and evidence of mild dopamine-beta-hydroxylase deficiency and no
alterations in the ATOX1 coding or splice junction sequences were found.
Conclusions:  In this study, we characterized the genomic structure of the human copper
chaperone ATOX1 to facilitate screening of this gene from genomic DNA in patients whose clinical
or biochemical phenotypes suggest impaired copper transport.
Background
Copper is an essential trace element that plays a role in
cellular respiration, antioxidant defense, neurotransmitter
biosynthesis, connective tissue biosynthesis and pigment
formation and is critical for the survival of all living organ-
isms. A family of eukaryotic cytoplasmic proteins termed
copper chaperones that bind copper ions and deliver
them to specific cellular pathways was discovered recently
[1]. The first copper chaperone, ATX1, is a cytosolic pro-
tein involved in an tio xidant defense and iron uptake, in
addition to copper trafficking in the yeast Saccharomyces
cerevisiae [2,3]. The human homolog of ATX1 was isolated
by screening a liver cDNA library, and named HAH1 (for
human ATX homolog 1) [4]. This gene maps to chromo-
some 5q32 [5], and is referred to synonymously as ATOX1
[6,7].
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Biochemical studies of ATOX1/HAH1 [8,9] indicate cop-
per-dependent interaction between this protein and two
human copper-transporting ATPases. These latter mole-
cules, encoded by the genes ATP7A and ATP7B, function
to convey copper through the secretory pathway of cells
including thetrans-Golgi  network. Mutations in ATP7A
and ATP7B produce characteristic clinical phenotypes:
Menkes disease and occipital horn syndrome, allelic X-
linked recessive traits [10,11], and Wilson disease, an au-
tosomal recessive trait, respectively.
Interestingly, disruption of the murine homolog (Atox1)
results in perinatal mortality and biochemical abnormali-
ties similar to that observed in the brindled mice (Mobr), a
mouse model for classical Menkes disease [12]. These cu-
mulative findings suggest that the ATOX1 and ATP7A
gene products are each integral to mammalian copper
transport, and that mutations in either could produce
similar clinical and biochemical phenotypes. Because of
our interest in the molecular basis of such phenotypes, we
determined the intron-exon boundaries of ATOX1 to ena-
ble mutation screening from genomic DNA, and analyzed
splice junctions and coding sequences in several relevant
patients.
Results and Discussion
Genomic structure of ATOX1 and mutation analysis
We identified 4 exons and 3 introns in ATOX1 that span a
genomic distance of approximately 16 kb (Figure 1). The
apparent translation start codon is located in exon 1, and
the termination codon in exon 3. We used 5' and 3' ran-
dom amplification of cDNA ends (RACE) to obtain the 5'
and 3' ends of the ATOX1 cDNA sequence. We identified
3 splice donor and 3 splice acceptor sequences and did
not characterize the 5' intron/exon boundary of exon 1
and the 3' exon/intron boundary of exon 4 (Table 1). The
5' exon 1 sequence (untranslated) we obtained by 5' RACE
is 60 bp shorter than the cDNA sequence initially de-
scribed [5]. The three introns in ATOX1 were 6764 bp (in-
tron 1), 5255 bp (intron 2), and 3320 bp (intron 3).
Exons 2 and 3 were 76 bp and 171 bp in length, respec-
tively. The entire genomic sequence determined was sub-
mitted to GenBank (Accession number AY165037).
Based on these findings, we designed PCR primers (Table
2) that efficiently amplify all 3 coding exons and the rele-
vant splice junctions (Figure 2). We analyzed ATOX1 in
several patients whose clinical or biochemical features
were suggestive of abnormal copper transport. These in-
cluded 2 of 49 patients with phenotypes consistent with
classical Menkes disease [10], and a previously reported
Figure 1
The genomic structure of the Atx1 human homologue. The translation start codon is located in the 3' end of exon 1 and the 
termination codon is in exon 3. The complete intronic and exonic sequences determined have been submitted to GenBank 
(Accession number: AY165037).
Table 1: Intron/Exon junctions of ATOX1. The nucleotide sequences of intron/exon junctions are shown by uppercase letters for exons 
and by lowercase letters for introns. The GT-AG conserved splice junction sequences are seen in all three introns.
Exon Splice acceptor Exon sequence Splice donor
1 AGGCGCTGCT---(> 59bp)---AGTCATGCCG gtgagtggttgcgccgtccc---
2 ---tccccctgtgtttgtttcag AAGCACGAGT--- (76bp)---AAGCTTGGAG gtgagtgagtggccctgagt---
3 ---cccatttcctcttcctgcag GAGTTAAGTA---(171bp)---AAGGGGGCAG gtgggtaaggccccagcact---
4 ---taactttccatctttcctag GATGCTGATC----(136bp)---CTTTTGTTGG
-------ATGCCG
gtgagtggtt--- ~6.8kb ---tttgtttcag gtgagtgagt--- ~5.3kb ---cttcctgcag gtgggtaagg--- ~3.3kb ---tctttcctag
Exon 1 Exon 2 (76 bp) Exon 3 (171 bp) Exon 4
AAG----------------GAG GAG------TAG----CAG GAT----------BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/4
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patient with occipital horn syndrome [13], in none of
whom ATP7A mutation have been identified. A fourth pa-
tient tested for ATOX1 alterations was a 43 year old female
with a history of chronic anemia, low serum copper and
mild dopamine-beta-hydroxylase deficiency, which re-
sponded to oral copper replacement (data not shown).
We detected no alterations in the ATOX1 coding or splice
junction sequences in any of these individuals.
Characterization of the genomic structure of ATOX1 ena-
bles rapid and efficient mutation screening from genomic
DNA. Identification and clinical/biochemical delineation
of patients in whom alterations in ATOX1 are found will
permit better understanding of the significance of this
gene product in human trace metal metabolism. In addi-
tion, functional polymorphisms in ATOX1 may be rele-
vant in terms of phenotypic modifier effects in these
copper transport disorders.
Conclusions
In this study, we determined the genomic structure of
ATOX1 to facilitate screening of this gene in patients with
clinical and biochemical findings suggestive of disordered
copper homeostasis.
Figure 2
PCR products of 3 coding exons of ATOX1 in 2 % agarose gel. 100 bp nucleic acid markers is shown in M and exons are 
shown in numbers.
Table 2: Oligonucleotide primers used to amplify ATOX 1 coding sequences and splice junctions
Exon Forward Primer (5'-3') Reverse Primer (5'-3') Fragment Size
Exon 1 aggcgctgctgacaccgccg ttcaagatcagcatccggtc 151 bp
Exon 2 aggcttctgatgagtctgatgc tctgcatgcatctgaacatg 273 bp
Exon 3 tgagtagtaatttagagcctg aggtgttcgctctgatgagag 327 bp







327 bpBMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/4
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Methods
Subjects
Peripheral blood specimens or skin fibroblast cultures
were obtained from two individuals diagnosed with clas-
sical Menkes disease on clinical and biochemical grounds,
one patient with occipital horn syndrome [13], and one
adult female with a history of chronic anemia, low serum
copper and ceruloplasmin, and abnormal plasma cate-
cholamine levels consistent with mild deficiency of
dopamine-β-hydroxylase, a copper-requiring enzyme. Ge-
nomic DNA was isolated from white blood cells or fibrob-
lasts using the Wizard® Genomic DNA Purification Kit
(Promega) according to the manufacturer's instructions.
The studies were approved by the NICHD and NINDS In-
stitutional Review Boards.
PCR amplification
Oligonucleotide primers for PCR amplification were de-
signed from the published cDNA sequence of the human
homologue of ATOX1 gene [4]. Each PCR reaction con-
tained a final concentration of 1X optimized PCR buffer J
(Invitrogen), 500 nM each PCR primer, 200 µM dNTP and
1.5 U Taq DNA polymerase (Life Technologies Inc.). 200
ng of genomic DNA was added to the total volume of 50
µl PCR reaction. These PCR reactions were then denatured
for 5 minutes at 94°C in a Perkin-Elmer 9700 thermocy-
cler; followed by 35 cycles of 94°C for 30 seconds, 55°C
for 45 seconds and 72°C for 2 minutes; then with a final
extension of 72°C for 7 minutes. Oligonucleotide primer
sequences used to amplify ATOX 1 coding sequences and
splice junctions are shown in Table 2.
5' and 3' RACE
The rapid amplification of 5' and 3' ends of cDNA (RACE)
was performed with Marathon-Ready™ cDNA kit (Clon-
tech), which is essentially an uncloned library of adaptor-
ligated double-stranded cDNA. Both 5'-and 3'-RACE reac-
tions were primed with an internal gene-specific primer
(GSP) and the Marathon adaptor primer (AP). The adap-
tor-ligated cDNA does not contain a binding site for the
AP. During the first round of thermal cycling, the GSP is
extended to the end of the adaptor, creating an AP binding
site at the 5' (or 3') terminus of the cDNA. In subsequent
cycles, both the AP and the GSP can bind, allowing expo-
nential amplification of the cDNA of interest.
Long PCR
To amplify the intronic regions of ATOX1, long PCR am-
plifications were performed in volume of 50 µl reactions
by using the Expand Long Template PCR system kit (Ro-
che). Each reaction contained 2.5 U Taq and Pwo DNA
polymerases, 1X supplied buffer with 2.25 mM MgCl2,
500 µM dNTP, 300 nM each forward and reverse primers
and up to 500 ng genomic DNA. The reaction were opti-
mized as follows: an initial denaturation for 2 minutes at
93°C, followed by 10 cycles of 93°C for 10 seconds, 65°C
for 30 seconds and alternated with 68°C for 4 minutes.
For the next 20 cycles, the temperature profile was modi-
fied by the addition of increments of 20 seconds to each
extension step at 68°C. A 7 minutes final extension period
at 68°C was incorporated after the last cycle of long PCR
reaction.
DNA Sequencing
Sequence analysis was performed on an ABI 377 automat-
ed DNA sequencer at the National Institute of Neurologi-
cal Disorders and Stroke, National Institute of Health,
DNA Sequencing Facility.
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